版本:
中国

BRIEF-Cymabay therapeutics announces newly issued U.S. patent for MBX-8025

Oct 11 Cymabay Therapeutics Inc

* Announces a newly issued U.S. patent for MBX-8025 for the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

* Patent claims methods of treating NAFLD,NASH comprised of orally administering therapeutically effective amount of MBX-8025 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐